Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

PODs Alert: HHS Inspector General Issues Fraud Warning For Physician-Owned Device Distributors

This article was originally published in The Gray Sheet

Executive Summary

The March 26 special fraud alert reiterates the HHS watchdog’s “longstanding position that the opportunity for a referring physician to earn a profit, including through an investment in an entity for which he or she generates business, could constitute illegal remuneration under the anti-kickback statute.”

You may also be interested in...



POD Pressure: Senators Scrutinize Physician-Owned Distributorships At Hearing

A Nov. 17 Senate Finance Committee hearing advanced an ongoing investigation into the impact of physician-owned distributorships of medical devices on health care, including the concerns they raise over potential conflict of interest and risks to patient safety.

Inspector General: Physician-Supplied Spinal Devices Associated With More Surgeries, Potential Cost Increase

A study by the HHS Office of Inspector General finds that use of spinal devices supplied by physician-owned distributors may lead to an increase in spine surgeries and increased costs to Medicare.

Medtronic “Repurposes” Spine Convention Booth To Tell Its Side of BMP Story

The firm’s bare-bones booth at the North American Spine Society annual meeting was a conspicuous sign of strains between Medtronic and the clinical group over how issues surrounding its rhBMP-2 Infuse bone graft have been presented.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT031929

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel